Dual NRT
PreclinicalSmall molecule
Dual NRT is one of 41 small molecule programs targeting Recovery. It is currently in Preclinical.
2
Indications
1
Total Trials
1
Active Trials
40
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
48 competitors in Opioid Use Disorder
#DrugCompanyPhaseTrials
1Suboxone
IIndivior Inc.
Approved
Sovaldi
GileadApproved
Dolophine
HHikma Pharmaceuticals LLC
Approved
Cabenuva
GSKApproved
Oxycontin
PProtega
Approved
Dilaudid
RRhodes Pharmaceuticals, L.P.
Approved
Lucemyra
BBioCorRx Pharmaceuticals Inc
Approved
Narcan
SScienture
Approved
MS Contin
HHikma Pharmaceuticals LLC
Approved
Cyklokapron
JJ Molner
Approved
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Dual NRT. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- MMassachusetts General Hospital